Allosteric, chiral-selective drug binding to DNA
The binding interactions of (−)-daunorubicin (WP900), a newly synthesized enantiomer of the anticancer drug (+)-daunorubicin, with right- and left-handed DNA, have been studied quantitatively by equilibrium dialysis, fluorescence spectroscopy, and circular dichroism. (+)-Daunorubicin binds selective...
Gardado en:
| Publicado en: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
National Academy of Sciences
2000
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC17289/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11027298/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.200221397 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|